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Abstract
Background Cognitive impairments in patients with myotonic dystrophy type 1 (DM1) have often been described, however, 
there are only few studies differentiating between partial performance disorders and mental retardation in common. This 
study focused on the evaluation of reading performance and the frequency of dyslexia in adult DM1 patients.
Methods We performed a prospective cohort study including genetically confirmed adult DM1 patients registered in 
the DM registry of Germany or the internal database of the Friedrich-Baur-Institute, Munich, Germany. For the assess-
ment of the patients’ reading and spelling performance, we used the standardized and validated test ‚Salzburger Lese- und 
Rechtschreibtest‘ (SLRT II). The ‚CFT-20 R Grundintelligenztest Skala 2‘ in revised ("R") version (CFT 20-R), determin-
ing the intelligence level, was appropriate to differentiate between dyslexia and general mental retardation. The diagnosis 
of dyslexia, the combined reading and spelling disorder, was based on the guidelines for diagnosis and therapy of children 
and adolescents with dyslexia 2015 (S3-guideline) providing (1) the criterion of the divergence from age level and (2) the 
criterion of IQ-divergence.
Results Fifty-seven DM1 patients participated in our study. Evaluating the reading performance, 16 patients fulfilled the 
divergence criteria of the age level and 2 patients the IQ-divergence criteria. In total, the diagnosis of a reading disorder 
was given in 18 DM1 patients (31.6 %). In 11 out of these 18 patients with a reading disorder, a relevant impairment of 
spelling performance was observed with at least three spelling errors. As there are no normative values for adults in spell-
ing performance, we assume a combined reading disorder and dyslexia, in those 11 DM1 patients (19.3 %). Regarding the 
separate analyses of the test procedures, in the SLRT II the performance was below average in 40.4 % of all patients for 
‘word reading’ and in 61.4 % of all patients for ‘pseudoword reading’. There was a significant positive correlation between 
the CTG expansion size and a reading disorder (p=0.027). The average IQ of 17 examined DM1 patients was in the lower 
normal range (86.1 ± 19.1). 54.5 % of patients with reading disorder had a normal IQ.
Conclusion The calculated prevalence of dyslexia in the DM1 study cohort was 19.3 % and thus considerably increased 
compared to the normal German population. As dyslexia is not equivalent to a general cognitive impairment, it is important 
not to miss dyslexic features in cognitive inconspicuous DM1 patients. Case-by-case one should consider a differential 
diagnostic approach, as individualized therapies can be offered to support dyslexic patients in their performance.
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Introduction
With an approximate prevalence of 10–20 to 100,000 peo-
ple, myotonic dystrophy type 1 (DM1) is one of the most 
frequent inherited neuromuscular diseases in adulthood [1, 
2]. This multisystemic disorder is caused by a genetic muta-
tion of the dystrophia myotonica protein kinase (DMPK) 
gene on chromosome 19q13.3, overexpressing the CTG tri-
plet with at least 50 repeats [3–5]. The autosomal dominant 
inheritance of DM1 is accompanied by the phenomenon of 
 * B. Schoser 
 benedikt.schoser@med.uni-muenchen.de
1 Department of Neurology, Friedrich-Baur-Institute, 
Ludwig-Maximilians-University Munich, Ziemssenstr. 1a, 
80336 Munich, Germany
 Journal of Neurology
1 3
anticipation, which is defined as an increased expansion in 
successive generations accompanied by an earlier and more 
severe disease course [6]. Specific for DM1 is a severe con-
genital form. In these patients, first symptoms appear from 
birth. More frequently however is the adult form with an 
age of onset in the adolescents. As to date, there is no causal 
treatment of DM1, thus the therapeutic focus remains on 
symptomatic treatments [7].
The clinical core pattern of the adult DM1 includes a 
progressive muscle weakness from distal to proximal and 
axial combined with myotonic syndrome focused on the 
hand muscles [8]. Next to various multisystemic symptoms 
like cataract, jaw and swallow difficulties, gastrointestinal 
and endocrine involvements, it is the cardiac and respiratory 
dysfunction defining the severity of this disease [8]. Besides, 
the variety of cognitive and neurophysiological impairments 
in DM1 has been frequently described in the past [9–12]. 
The fatigue syndrome including daytime sleepiness, lack 
of motivation, difficulty in concentration and unrefresh-
ing naps affects many DM1 patients [10]. These features of 
myotonic dystrophy often affect the patients’ daily quality 
of life and restrict the ability for social participating and to 
work substantially more than the pure muscular symptoms 
[13]. Researches detected a high incidence of psychiatric 
co-diagnoses in DM1 patients e.g. attention-deficit/hyperac-
tivity disorder (ADHD), phobia or alexithymia [9]. Recent 
findings indicated a conspicuous prevalence of autistic 
spectrum in DM1 [11]. A wide-ranging cognitive retarda-
tion was reconnoitred, particularly for congenital and early-
onset DM1 patients. Stereotypically, multiple DM1 studies 
report an IQ level in the lower normal range combined with 
decreased intellectual abilities [12, 14].
There are only a few studies about dyslexic phenomenon 
in DM1 patients [15, 16]. The case report by Macniven [16] 
presents a DM1 patient with progressive dyslexia followed-
up of more than 10 years. Dyslexia is a partial performance 
failure in reading and spelling which is not only caused by a 
delayed development in cognition or intelligence [17]. Even 
in the normal population, about 5% of children and adoles-
cents are affected by dyslexia [18, 19]. Chief symptoms of 
a reading disorder include a significant slow reading speed 
and consequently difficulties in getting the content right. As 
the association of individual letters with their corresponding 
sound is affected, people with reading disorder tend to inter-
change or skip single letters, especially in complex, polysyl-
labic and rare words and stressful situations [17]. A spell-
ing disorder presents by a noticeable increased number of 
spelling errors. Moreover, patients with a spelling disorder 
try to elude words that probably cannot be spelled correctly 
to avoid spelling errors [17]. Usually, dyslexia is an impair-
ment of young people, however, adults can be involved as 
well. Most diagnostic test manuals are not provided for all 
ages. Only a few standardized tests can be partially used 
for dyslexia diagnosis in adulthood (e.g. reading disorder: 
‘Salzburger Lese- und Rechtschreibtest’ (SLRT II) [20]). 
Normative values for the spelling performance in adults do 
not exist in German test measurements. The comparison of 
the patients’ test results with the performance of people in 
the same age, or school year, leads to a percentage ranking 
(PR). Another important component of the diagnosis of dys-
lexia consists of the assessment of the intelligence, including 
the evaluation of logical thoughts and processing speed [17]. 
Analogous to the diagnosis of dyslexia, treatment options, 
e.g. reading training, became established especially for chil-
dren and adolescents however not for adults [21]. Indeed, 
most important is the clarification of the diagnosis dyslexia 
to the patient and the social environment to ease the usually 
tensed situation. A psychotherapy could be indicated as well, 
as in 40% to 60% dyslexia is associated with psychological 
problems [17]. In common, it is difficult to find scientific 
appropriate data on dyslexia in adulthood, as most affected 
people are children or adolescents.
In patients with DM1, the dyslexic features do not fit into 
the syndrome of a developmental dyslexia, but rather look 
like a neurodegenerative process [16]. Brain MRI studies 
confirm a correlation between progressive cerebral atrophy 
and cognitive changes, with the focus of white matter lesions 
in the frontal and parietal lobe in dyslexic persons [22, 23]. 
As DM1 is known to belong to the spectrum of tauopathies, 
investigations of the cerebrospinal fluid revealed increased 
levels of phosphorylated tau protein, which is characteristic 
for the neurodegenerative disease and dementia [24]. Cur-
rent studies showed that adult DM1 is accompanied by cog-
nitive decline in memory, attention, visuospatial construc-
tion and verbal ability [25].
Our study investigated the prevalence of dyslexia in an 
adult DM1 cohort by assessing reading and spelling difficul-
ties using a validated test for dyslexia and an IQ test. One 
core item of our study was the differentiation of a general 
cognitive retardation to a partial performance failure in the 
reading performance in DM1 patients to enable a future opti-
mization of diagnostic and therapeutic options.
Patients and methods
We performed a prospective cohort study inviting adult 
patients with genetically confirmed DM1, recorded in the 
DM-registry of Germany or the internal DM-database of our 
neuromuscular department.
The inclusion criteria obtained the following aspects, (1) 
providing informed consent, (2) age ≥ 18 years, (3) sufficient 
knowledge of the German language evaluated by two inde-
pendent investigators.
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‚Salzburger Lese‑ und Rechtschreibtest‘ (SLRT II)
For the quantification of the reading performance, we used 
the validated test measurement SLRT II [20]. The SLRT II 
is a validated standardized test for the assessment of read-
ing and spelling disorders. According to the SLRT II test 
manual, especially for adults, the test requirements aim at 
the detection of deficits in automated, direct word recogni-
tion and of synthetic reading, and the detection of weak-
ness in (non-)orthographic writing. Since the letter-to-sound 
relationship and thus the reading accuracy is usually very 
high after the first year of school, reading errors are made in 
the German-speaking area especially, when reading is faster 
than the reader’s abilities allow. The reading accuracy itself, 
thereby, may not differentiate sufficiently between bad and 
good readers. On the contrary, the decisive factor is how 
efficiently, i.e. quickly and fluently, reading is performed. 
Therefore, reading speed has emerged in recent years as the 
central criterion for reading performance. Accordingly, the 
focus of the SLRT II is certainly on the reading fluency and 
speed, but can nevertheless, based on the above explanation, 
not only be regarded as a reading fluency task, but as a read-
ing task in general. Reading errors are taken into account 
to the extent that the number of incorrectly read words is 
subtracted from the total number. Reading errors and reading 
time are thus included in a combined value.
In Detail there are two patterns, consisting of 156 words 
and 156 pseudo-words. Pseudo-words are composed of 
single letters that do not add up to a familiar word (e.g. 
‘mume’). In the first step, the ‘word’ reading test serves pri-
marily to capture automatic, direct word recognition, while, 
in the second step, the ‘pseudo-word’ reading test serves 
primarily to capture synthetic reading, i.e. the letter-to-sound 
relationship. The aim of the test is in the first step to read as 
many words as possible precisely within one minute, in the 
second step as many pseudowords. The number of correctly 
read (pseudo-)words results in a percentage ranking (PR: 
0–100). The lower the PR, the worse the reading perfor-
mance, e.g. if a participant reaches a PR of 20, it means that 
80% scored a better test performance than this participant 
did.
The analysis of spelling errors distinguishes between 
(non-)orthographical errors (NO-errors) and case sensitiv-
ity. N-errors are misspelled words that do not match with 
the word sound of the test word (for example child – > chid 
or chilb). O-errors are spellings that match with the sound 
of the word, but do not represent the grammatically correct 
spelling (for example, child – > chilt or chilld). In addition, 
the test detects errors in upper and lower case in the spelling 
test (case sensitivity). The number of NO-errors results in 
a percentage ranking (> 2 errors → PR ≤ 80), errors in case 
sensitivity are based on a critical value of 3.
CFT‑20 R Grundintelligenztest Skala 2‘ in revised 
("R") version (CFT 20‑R)
To differentiate between dyslexia and a general cognitive 
impairment, the CFT 20-R was used to assess the IQ [26]. 
Features as faculty of abstraction, processing speed and logi-
cal reasoning are explored by the CFT 20-R. All subtests 
increase in the level of difficulty. Similar to the SLRT II, 
the number of correctly solved tasks within a defined time 
of 3–5 min ends up in an IQ level.
Diagnosis of dyslexia
The diagnosis of dyslexia in our study was based on the 
guidelines for diagnosis and therapy of children and ado-
lescents with dyslexia 2015 (S3-guideline) [21]. There are 
two criteria used in this study provided by the guideline, 
(1) criterion of the deviation from age level and (2) crite-
rion of IQ deviation. The first criterion is met by patients 
with a reading performance at least 1.5 standard deviations 
(SD) below the mean of the same age level. Besides, the 
guideline presents the criterion of IQ deviation, which can 
be only used for patients with a below-average reading per-
formance (> 1 SD below normal range). Depending on the 
patients’ IQ, an appropriate PR is expected for the reading 
Table 1  Diagnostic criteria for dyslexia due to guidelines for diagnosis and therapy of children and adolescents with dyslexia 2015 (S3-guide-
line)
Diagnostic criteria for dyslexia
Diagnostic criteria Content Transformation
Criterion of age level divergence Below-average performance according to the age norm 
(> 1.5 SD below normal range) in both subtests 
(pseudo-) word reading
PR < 8 (words) and
PR < 11 (pseudo-words)
Criterion of IQ-divergence Below-average performance in on subtest of the reading 
performance according to the age norm (> 1 SD below 
normal range) AND
PR in the reading tests 1 SD below the expected PR due 
to the IQ level
PR ≤ 16
AND
Discrepancy > 1 SD between 
reached PR and expected PR due 
to the IQ
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performance. Patients with reading difficulties reaching a 
PR, which is 1 SD below the expected PR, fit the criterion 
of IQ divergence. In general, test results of the SLRT II 
being at least 1 SD below the average can be interpreted as 
reading difficulties (cutoff value PR ≤ 16, e.g. ≤ 96 correctly 
read words and ≤ 55 pseudo-words). Further cutoff values 
are summarized in Table 1.
The data of this study were statistically analyzed with 
SPSS Statistics 25. For the characterization of the DM1 
cohort, the assessment of dyslexic features and for the cal-
culation of reading difficulties, descriptive and explorative 
testing was used. Further statistical analysis was explored 
with the t-test, comparing the mean values of two independ-
ent groups. Normal distribution was determined using the 
Shapiro–Wilk test and Kolmogorov test. The relationship 




Fifty-seven adult patients with genetically confirmed DM1 
participated in this study. With a female ratio of 40.4%, 
the mean age (normal distributed) at testing is 41.4 ± 12.2 
years (min–max 18–67; median 43), the mean age of onset 
is 23.2 ± 13.6 years (min–max 3–54; median 21), the mean 
duration of disease is 18.0 ± 9.5 years (min–max 2–43; 
median 16.5) (Fig. 1). The genetic testing of the study par-
ticipants was not performed at the same time as the assess-
ment of reading and spelling performance but goes back to 
the year 1989 in single cases. On average, the CTG expan-
sion is 475 ± 332 triplets (min–max 75–1550; median 375; 
N = 55), of these 30.9% < 300, 43.6% between 301 and 600, 
16.4% between 601 and 900 and 9.1% > 900 CTG. The mus-
cular impairment of all patients was explored by the muscu-
lar impairment rating scale (MIRS): 0 patients MIRS 1; 15 
patients (26.3%) MIRS 2; 24 patients (42.1%) MIRS 3; 15 
patients (26.3%) MIRS 4; 3 patients (5.3%) MIRS 5.
Dyslexia
Reading disorder
The number of correctly read (pseudo-)words within one 
minute results in a percentile ranking (PR). 16 DM1 patients 
(28.1%) of 57 tested study participants had a reading per-
formance 1.5 SD below average values in both, word and 
pseudo-word reading. These patients meet the criterion of 
age level divergence (→ 2 Methods). Further values for read-
ing difficulties and normal reading performances are sum-
marized in Table 2.
Those patients that did not meet the criterion of age level 
divergence were tested for the criterion of IQ-divergence 
(→ 2 Methods). Two of these patients had a below-average 
Fig. 1  DM1 cohort (N = 57) for 
age at testing, age of onset and 
duration of disease
Table 2  Reading performance due to SLRT II
Reading performance in SLRT II
Deviation from 
normal value
PR word reading N (%) PR pseudo-word 
reading
N (%) Intersection N (%)
Reading disorder/read-
ing difficulties
 > 1 SD  ≤ PR 16 23 (40.4)  ≤ PR 16 35 (61.4) 22 (38.6)
Norm range  < 1 SD  > PR 16 34 (59.6)  > PR 16 22 (38.6) 21 (36.8)
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performance in one reading subtest according to the age 
norm (> 1 SD below normal range) and a reading perfor-
mance beneath the PR that was expected due to the IQ value 
(> 1 SD below expected PR).
Summing up, the prevalence of a reading disorder in the 
examined DM1 cohort was 31.6% (16 + 2 patients) (Fig. 2). 
54.5% of these patients with a reading disorder performing 
an IQ test reached a normal IQ within 85–115.
There are no significant differences between patients with 
and without reading disorder according to the age of onset 
(p = 0.160) and duration of disease (p = 0.969). A differ-
ence was found in regards of the repeat length being signifi-
cantly increased with 621 ± 100 CTG (median 565 CTG) in 
patients with reading disorder, compared to DM1 patients 
without a reading disorder with 409 ± 44 CTG (median 350 
CTG) (p = 0.027). The gender ratio (female:male) was ≈ 1:5 
for DM1 patients with reading disorder, and ≈ 1:1 for DM1 
patients without reading disorder.
Spelling disorder
There exists no appropriate German test manual for the diag-
nosis of a spelling disorder adapted for adults. Therefore, 
the criteria of the S3-guideline cannot be transferred to the 
results of the DM1 cohort in the SLRT II one-by-one, as the 
reference values for spelling difficulties in this test are only 
gathered for children.
In summary, in 11 out of 18 patients with a diagnosed 
reading disorder, at least 3 spelling errors had been observed 
and therefore correspond to a percentage ranking ≤ 80 that is 
equivalent to a spelling disorder due to the given reference 
values for children.
Diagnosis of dyslexia (combined reading and spelling 
disorder)
With reservations, a combined reading and spelling disorder, 
dyslexia, can be assumed in 11 DM1 patients (19.3%), since 
the criteria for a reading disorder are fulfilled in 18 DM1 
patients, and a spelling disorder can be assumed in 11 of 
these patients based on reference values for children.
Individual results of the SLRT II
In word reading, 40.4% had a below-average reading perfor-
mance (reading difficulties or reading disorder), in pseudo-
word reading there were 61.4% with a reading performance 
below the normal range (Table 2). On average correctly 
read words within one minute were 95.0 ± 21.8 (min–max 
35–126; median 101; mean PR 12–13) for word reading and 
49.4 ± 17.9 (min–max 17–87; median 48; mean PR 8–10) 
for pseudo-word reading. The PR of word and pseudo-
word reading correlates significantly in a moderate degree 
(r = 0.772; p = 0.01) (Fig. 3).
The reading performance of the DM1 cohort tends to 
decline with an increasing MIRS, however not significant in 
the Spearman correlation (word reading p = 0.081; pseudo-
word reading p = 0.314) (Fig. 4, Table 3).
Individual results of the CFT 20‑R (IQ value)
The IQ test was performed by 17 DM1 patients. The aver-
age IQ was 86.1 ± 19.1 (min–max 54–123; median 82). In 
total, 41.2% (7 patients) reached an IQ in the normal range 
Fig. 2  Reading disorder—cri-
terion of age level divergence. 
Key notes Reading disorder: 
PR [word reading] < 8 and PR 
[pseudoword reading] < 11. 
Severe reading difficulties: (1) 
PR [word reading] < 8 and PR 
[pseudoword reading] 11–16. 
(2) PR [word reading] 8–16 and 
PR [pseudoword reading] < 11. 
(3) PR [word reading] 8–16 
and PR [pseudoword reading] 
11–16. Mild reading difficulties: 
(1) PR [word reading] in normal 
range and PR [pseudoword 
reading] ≤ 16. (2) PR [word 
reading] ≤ 16 and PR [pseudow-
ord reading] in normal range. 
Normal reading performance: 
PR [word reading] and PR 











Severe reading difficules (1)
Severe reading difficules (2)
Severe reading difficules (3)
Mild reading difficules (1)
Mild reading difficules (2)
Normal range
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[100 ± 15 (1 SD)]. There was a significant difference between 
the average IQ of patients with maternal (97.9 ± 20.2) and 
paternal (77.9 ± 13.8) inheritance (p = 0.029). The compari-
son of the average IQ of female and male DM1 patients was 
inconspicuous (p = 0.803).
Discussion
A general cognitive retardation has been frequently proposed 
for DM1. Studies deciphering differentiations between a 
general intelligence impairment and partial performance 
failures in reading- and spelling performance are rare [8, 15, 
18, 27]. Our study focused on the feature of dyslexia and its’ 
prevalence in an adult DM1 cohort by using a validated test 
battery for the quantification of the patients’ reading- and 
spelling performance, and an IQ test for differentiating of a 
more general cognitive retardation.
The diagnosis of dyslexia is quite complex and based 
on a multiaxial classification system for mental disorders 
including a six-axis system. The first axis covers the clinical-
psychiatric syndrome, the second refers to the circumscribed 
developmental deficits, the third to the intelligence level, 
the fourth to the physical symptoms, the fifth to abnormal 
associated psychosocial circumstances and the sixth to the 
global assessment of the psychosocial functional level. The 
abbreviated testing procedure used in our study represents 
a screening method, performed by validated and standard-
ized tests. Reading tests validated for the adulthood are rare, 
spelling problems are even more difficult to explore, as there 
Fig. 3  Correlation of word and pseudo-word reading performance in the SLRT II [PR]
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are no appropriate German tests with cut-off levels. There-
fore, the lack of reference values for spelling in adults makes 
it difficult to make a definitive diagnosis of dyslexia. The 
SLRT II provides reference values for adults in reading, but 
only for children in spelling. So all spelling errors made by 
adult patients examined in our DM1 cohort weigh even more 
as the test is adapted for children. Using the reference values 
set for children in an adult collective will probably result 
in a high false negative number rather than patients with a 
spelling disorder are recognized as unremarkable. To put it 
another way, patients with three errors in a test designed for 
children, would probably perform even worse in a validated 
test battery for adults. Consequently, the risk of a false posi-
tive result of the prevalence of dyslexia in our DM1 cohort 
is neglectable. With a frequency rate of 19.3% of dyslexia 
in DM1, this rate clearly exceeds the rate of 5% found in the 
normal population [18]. Our high prevalence of dyslexia in 
DM1, determined in this study, stays presently monolithic, 
as there are no comparable studies available. Nevertheless, 
a follow-up screening will be of interest exploring the DM1 
patients’ reading performance over time.
The study by Macniven presented an unusual long-
term case of an adult DM1 patient over 16 years. Part of 
the assessments was the evaluation of the patient’s read-
ing performance in regular and exception words. At the first 
reading assessment, 20 years after being diagnosed with 
DM1, the patient’s reading skills were only mildly impaired 
on exception words. Throughout the follow-up of the next 
10-years, the authors reported a deterioration in both, regu-
lar and exception word reading. Similarities to a semantic 
dementia had been weighed controversially in this report. 
The observed cognitive decline was associated with a dete-
rioration of the full scale IQ as well [16]. Analogous to our 
results, the patient’s reading performance was more accurate 
at reading regular (words) than exception (pseudo-words) 
words. These results correspond with the observation that 
unknown words (pseudo-words, exception words) are more 
difficult to be read correctly, as familiar words can be rec-
ognized as total and do not have to be read letter-by-letter. 
Consequently, people with dyslexic features have difficulties 
more with pseudo-words than with normal, familiar words.
The comparison of patients with and without a reading 
disorder according to the age of onset and duration of disease 
was inconspicuous. Only the variable CTG-repeat length 
revealed a low significant difference, as dyslexic patients 
had a longer CTG-repeat expansion on average than non-
dyslexics. This correlation between IQ/neurophysiological 
test results and CTG-repeat length was evident in prior stud-
ies [28–30]. Moreover, a trend of a decreasing reading per-
formance with an increasing score on the Muscular Impair-
ment Rating Scale (MIRS) was obvious in our DM1 cohort. 
The CTG expansion as cofounder for cognitive (reading 
performance) and muscular impairment (MIRS) could be 
Fig. 4  Reading performance—
measured by the total number of 
correct read (pseudo-)words—
differentiated by the level of 
muscle strength—measured by 
the Muscular Impairment Rat-
ing Scale (MIRS) (blue: word 
reading; green: pseudo-word 
reading)
Table 3  Correlation between muscular impairment (MIRS) and read-
ing performance (number of correctly read words)
Correlation between MIRS and reading performance
Word reading (N ± SD) Pseudo-word 
reading 
(N ± SD)
MIRS 1 – –
MIRS 2 103 ± 14 49 ± 16
MIRS 3 95 ± 23 54 ± 20
MIRS 4 89 ± 24 45 ± 17
MIRS 5 84 ± 30 36 ± 8
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an explanation for this observed connection. However, the 
year of the performed genetic diagnosis of our study par-
ticipants varies between 1989 and 2016, so we do not know 
the current repeat length at the time of our present testing. 
The fluctuation of the CTG repeat length over time has not 
yet been finally clarified [31]. A statement about the corre-
lation between CTG expansion and dyslexic features would 
be more precise in case of quantifying the reading perfor-
mance and the genetic testing in the same year. The gender 
ratio between male and female of 5:1 in the DM1 collective 
with a reading disorder is consistent with reference values in 
the normal population [32]. Finally, whether specific RNA 
splicing events, e.g. of the FOXP2 gene, a gene implicated 
in speech and language disorders, may contribute to this 
dyslexic features remain presently open [33].
Another important result to stress was our observation 
that 54.5% of DM1 patients with diagnosed reading disor-
der achieved an IQ within the normal range. This empha-
sizes an independence of dyslexia and IQ. Neither a normal 
IQ excludes the coincidence of dyslexia, nor a below the 
average IQ is equivalent to dyslexic difficulties. This find-
ing should have an impact on therapeutic interventions. It is 
important to realize that people scoring a normal or above-
average IQ, nevertheless might need support regarding their 
dyslexia. Cohen et al. [15] report about children with a high 
verbal IQ which were benefitting from a special reading 
training.
Cognitive impairment is a well elaborated finding in 
congenital and early-onset DM1 patients. Several studies 
explored the intelligence level for congenital and juvenile 
DM1, in the majority of cases scoring a below-average IQ 
[14, 34]. The average IQ in our adult DM1 cohort counts in 
the lower normal range with 86.1, which is consistent with 
other study results reporting an average IQ of 82.6 in adult 
DM1 patients [28]. Moreover, we observed that the average 
IQ in cases of maternal inheritance exceeds significantly 
the value of patients with paternal inheritance. Due to the 
small number of patients, however, this finding needs to be 
interpreted with caution, since maternal inheritance is more 
typically associated with the phenomenon of anticipation, 
and the occurrence of CDM. Considering the average IQ 
regarding gender differences, there was no difference found 
between male and female patients. However, a nationwide 
DM1 cohort reported about a tendency of men being more 
frequently cognitive impaired than women [35].
Next to some clinical studies that hint at a neurodegen-
erative cognitive decline in DM1 patients [16], explorations 
of cerebrospinal fluid detected increased levels of phos-
phorylated tau proteins, however, with an unclear clinical 
relevance [24, 36]. Others identified pathological tau pro-
tein pattern in DM1 patients that are more consistent with 
Alzheimer disease [37]. The neurodegenerative process in 
DM1 has been evaluated in several brain MRI studies. The 
results are still somewhat inconsistent concerning frequency, 
extent and significance of the deviations in brain structures. 
The cerebral changes are focused in the frontal and parietal 
lobes and consist of volume reduction of grey matter and 
structural atrophy in the hippocampus [22, 38]. Anomalies 
in white matter are also reported in DM1, dominating the 
frontal and temporal lobes [38, 39]. Summing up clinical, 
histopathological, and imaging results, a neurodegenerative 
process becomes even more likely. Further studies examin-
ing the correlation between clinical behavior and changes in 
cerebral structures are indispensable, proving a relationship 
between neuropsychological performance and cerebral tissue 
modifications [22, 38, 39]. Moreover, long-term follow-ups 
are needed exploring the neurodegenerative base for DM1 
associated dyslexia.
Conclusion
Our study for the first time elaborated an increased preva-
lence of dyslexia in adult DM1 patients being independ-
ent of the general intelligence. A clinical consequence of 
our result is an early differential diagnostic assessment of 
the cognition in DM1. We see the need for distinguishing 
between a general cognitive impairment and partial perfor-
mance failure/disorder in reading and spelling. As dyslexia 
is independent of the general intelligence, it is important not 
to miss dyslexic features in cognitive inconspicuous DM1 
patients. The decision for a detailed diagnosis should be 
made case-by-case. As therapeutic options and individual 
support programs are available to support a sufficient edu-
cation for dyslexic people in school and higher education, 
an early diagnosis is essential, particularly for children and 
young adults.
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